WGS · GeneDx Holdings Corp. · Executive Compensation

$52.37 +0.50 (+0.96%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript

Russell 2000 member Rebalance outlook locked

Market Cap

$1.57B

29.97M

Volume · Nov 13 1.12M Avg daily vol (3M) 804.77K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Katherine Stueland	Chief Executive Officer	$715,869	—	$11,738,600	—	$1,075,500	$17,250	$13,547,219
Kevin Feeley	Chief Financial Officer	$500,600	—	$3,756,926	—	$414,150	$17,250	$4,688,926

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Katherine Stueland	CEO	$675,000	$950,000	$2,796,800	—	—	—	$4,421,800
Kevin Feeley	CFO	$450,000	$315,000	$568,100	—	—	$16,500	$1,349,600
Jason Ryan	Board Chair	$6,490	—	$338,480	—	—	$96,500	$441,470
Bryan Dechairo	Chief Operating Officer	—	—	—	—	—	—	—

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Katherine Stueland	CEO	$675,000	—	$2,829,420	—	—	—	$3,504,420
Kevin Feeley	CFO	$450,000	—	$1,086,035	—	—	$16,500	$1,552,535
Kareem Saad	Chief Transformation Officer	$375,000	—	$771,658	—	—	$41,360	$1,188,018
Jason Ryan	Board Chair	$343,471	—	$628,754	—	—	$16,500	$988,725
Bryan Dechairo	Chief Operating Officer	—	—	—	—	—	—	—

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Katherine Stueland	Chief Executive Officer	$453,557	$573,800	$5,445,707	$5,397,727	—	$11,563	$11,882,354
Kevin Feeley	Chief Financial Officer	$294,231	$191,300	$1,605,679	$1,542,770	—	$23,700	$3,657,680
Jason Ryan	Chairman of the Board	$510,923	$108,000	$1,658,374	$876,649	—	$39,515	$3,193,461
Eric Schadt	Ph.D. Former Chief Executive Officer, President, Chief Research & Development Officer and Director	$430,962	—	$1,116,215	$1,302,504	—	$311,931	$3,161,612
Kareem Saad	Chief Transformation Officer	$375,000	$34,000	$849,833	$762,927	—	$45,269	$2,067,029

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Eric Schadt	Ph.D. Former Chief Executive Officer, President, Chief Research & Development Officer and Director	$650,000	$513,000	$10,699,239	$3,867,064	—	$41,533	$15,770,836

Executive changes

Person	Role	Change	Effective	Filed
Mark Gardner	President	Appointed	2026-06-15	2026-06-16
Thomas Fuchs, Dr.sc.	Class I director	Appointed	2025-09-17	2025-09-18
Bryan Dechairo	Chief Operating Officer	Appointed	2025-01-02	2025-01-02
Dr. Michael Pellini	Board of Directors	Resigned	2023-02-14	2023-02-14
Kevin Feeley	Chief Financial Officer	Appointed	2022-08-25	2022-08-26

Leadership

Eric Schadt CEO, Board Member
Katherine Stueland CEO, Board Member
Kevin Feeley CFO
Richard Miao CFO
Bryan Dechairo COO
Bryan Dechairo, Ph.D. COO
Daniel Clark General Counsel
Dennis Charney Board Member
Dr. Emily Leproust Board Member
Dr. Sean George Board Member
Eli D. Casdin Board Member
Emily Leproust Board Member
Joshua Ruch Board Member
Keith Meister Board Member
Michael Pellini Board Member
Mr. Munib Islam Board Member
Mr. Nat Turner Board Member
Nat Turner Board Member
Rachel Sherman Board Member
Richard C. Pfenniger Board Member
Richard P. Pfenniger Board Member
Thomas Fuchs Board Member
Thomas Fuchs, Dr.sc. Board Member

Key facts CIK 1818331 CUSIP 81663L200 13F (30d) 171 filings 144 filers Visit website Investor relations